Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daan W. Von den Hoff"'
Autor:
Daan W. Von den Hoff, Floor A. C. Berden, Joost P. H. Drenth, Arnt F. A. Schellekens, HepNed, NISPA
Publikováno v:
Addiction Science & Clinical Practice, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background People who use drugs (PWUD) are at high risk for hepatitis C virus (HCV) infection and its complications. Given the high prevalence rate of HCV in PWUD, the World Health Organization (WHO) emphasizes PWUD as a target population fo
Externí odkaz:
https://doaj.org/article/5512f6b01f404c8f8571d739aec06c77
Autor:
Daan W. Von den Hoff, Floor A. C. Berden, Femke Atsma, Arnt F. A. Schellekens, Joost P. H. Drenth
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 4, p 1146 (2022)
The elimination of viral hepatitis in target populations is crucial in reaching WHO viral hepatitis elimination goals. Several barriers for the treatment of viral hepatitis in people with addictive disorders have been identified, yet nationwide data
Externí odkaz:
https://doaj.org/article/4db2fee6c70f4c69a7d16c10aecb1dc0
Publikováno v:
United European Gastroenterology Journal, 9, 10, pp. 1101-1102
United European Gastroenterology Journal
United European Gastroenterology Journal, 9, 1101-1102
United European Gastroenterology Journal
United European Gastroenterology Journal, 9, 1101-1102
Background Rates of Hepatitis C virus (HCV) testing and diagnosis are variable among people who use drugs (PWUD). In Puglia in 2018, of 871 subjects screened, 38% had HCV antibodies (HCVAb). Despite sustained virologic response at week 12 Sustained v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47074be08b900bc0108be8aba94f420f
https://repository.ubn.ru.nl/handle/2066/239440
https://repository.ubn.ru.nl/handle/2066/239440
Autor:
Merle de Zwart, Daan W. von den Hoff, Adriaan C.I.T.L. Tan, Auke Bogte, Manon C.W. Spaander, Peter D. Siersema, Elsa Soons, Bram D. Vermeulen, Lucie van der Weerd, M. J.M. Groenen, Vincenzo Craviotto, Alessandro Repici, Jasmijn Sijben, Daniele Arese
Publikováno v:
Gastrointestinal Endoscopy, 91(5), 1058-1066. Mosby Inc.
Gastrointestinal Endoscopy, 91, 5, pp. 1058-1066
Gastrointestinal Endoscopy, 91, 1058-1066
Gastrointestinal Endoscopy, 91, 5, pp. 1058-1066
Gastrointestinal Endoscopy, 91, 1058-1066
Endoscopic dilation (ED) is still the mainstay of therapeutic management of benign esophageal strictures (BESs). This study aimed to establish risk factors for refractory BESs and assess long-term clinical outcomes of ED.We performed a retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4daf097655b87d489c5d18397b8df2e5
https://pure.eur.nl/en/publications/54fdd335-7336-4e22-84cd-994b506aa2dc
https://pure.eur.nl/en/publications/54fdd335-7336-4e22-84cd-994b506aa2dc